PFIZER, INC.

DC

Pharmaceutical company

Active 2007–2026. The register lists this client once for every firm that files on its behalf; all 28 of its records are shown together here.

Filings
665
Filed By
28
Reported In-House
$232,960,000
Reported By Firms
$27,489,333

These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.

Filings

YearFirmPeriodAmountDoc
2026 MARSHALL & POPP, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 THE DUBERSTEIN GROUP INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 PFIZER INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$3,600,000
2026 MILLER STRATEGIES, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$150,000
2026 TODD STRATEGY GROUP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 THE WASHINGTON TAX & PUBLIC POLICY GROUP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
—
2026 PFIZER INC. 1st Quarter (Jan 1 - Mar 31)
AMENDED
$4,430,000
2026 TODD STRATEGY GROUP 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$60,000
2026 MILLER STRATEGIES, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$150,000
2026 PFIZER INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$1,880,000
Page 1 of 67  ·  665 filings Next
Filed By
Issue Areas

Bills Mentioned in Filings